Notice of Effectiveness (effect)
09 Abril 2018 - 7:02AM
Edgar (US Regulatory)
UNITED STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
Effective Date:
|
April 06,
2018
|
Form:
|
S-3
|
CIK:
|
0001404644
|
Company Name:
|
AQUINOX PHARMACEUTICALS, INC
|
File Number:
|
333-223584
|
Aquinox Pharmaceuticals (NASDAQ:AQXP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Aquinox Pharmaceuticals (NASDAQ:AQXP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Aquinox Pharmaceuticals Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Aquinox Pharmaceuticals, Inc